Dallas; Research Center
Study of investigational drug in patients with the brain tumor glioblastoma multiforme (GBM) who have progression or first recurrence following initial treatment with surgery, radiation and chemotherapy.
Houston; S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 In Adult Patients With Primary Malignant Brain Tumor
Houston; S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 In Adult Patients With Glioblastoma Multiforme
Houston; S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 Private In Patients With Neurofibroma And Schwannoma
Houston; S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 In Adult Patients With Mixed Glioma
Houston; S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 In Adult Patients With Oligodendroglioma
Houston; S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 In Adult Patients With Low Grade Astrocytoma
Houston; S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 and AS2-1 in adult patients with Anaplastic Astrocytoma
Houston; S. R. Burzynski Clinic
A phase II study demonstrate the antitumor activity of Antineoplaston A10 and AS2-1 in the treatment of children with rhabdoid tumor of the central nervous system by determining the proportion of patients who experience an objective tumor responses
Houston; S. R. Burzynski Clinic
A phase II study demonstrate the antitumor activity of Antineoplaston A10 and AS2-1 in the treatment of children with low grade astrocytoma by determining the proportion of patients who experience an objective tumor responses
Houston; S. R. Burzynski Clinic
A phase II study demonstrate the anti-tumor activity of Antineoplaston A10 and AS2-1 in the treatment of children with Primitive neuroectodermal tumors by determining the proportion of patients who experience an objective tumor responses.
Houston; S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 Private In Patients With Ependymoma
Houston; S. R. Burzynski Clinic
A phase II study to demonstrate the antitumor activity of Antineoplaston A10 and AS2-1 in the treatment of patients with brain stem glioma by determining the proportion of patients who experience an objective tumor response.
Houston; S. R. Burzynski Clinic
A phase II study to demonstrate the anti-tumor activity of Antineoplaston A10 and AS2-1 in the treatment of children with brain tumors by determining the proportion of patients who experience an objective tumor response
Houston; S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 Private In Children With Primary Malignant Brain Tumors
Houston; S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 Children With Visual Pathway Glioma
Houston; S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 In Patients With Brain Tumors
Houston; S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 and AS2-1 in Patients with Anaplastic Astrocytoma
Houston; S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2 1 In Patients With Glioblastoma Multiforme
Houston; S. R. Burzynski Clinic
A phase II BT-6 study of Antyneoplastons A10 and AS2-1 Infusions in Children with High Grade Glioma
Houston; S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 In Adult Patients With Meningioma
Houston; S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 Infusions Private In Patients With Germ Cell Tumor Of The Brain
Houston; S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 Infusions Private In Patients With Choroid Plexus Neoplasm
Houston; S. R. Burzynski Clinic
A phase II study of Antineoplastons A10 And AS2-1 Private In Patients With Craniopharyngioma
